Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from IMMUNOPHARMACOLOGY

  • You have access
    FK-506 and Cyclosporin A Potentiate the IgE Antibody Production by Contact Sensitization with Hapten in Mice
    Hiroichi Nagai, Hidetaka Hiyama, Akihiko Matsuo, Yoshifumi Ueda, Naoki Inagaki and Kenji Kawada
    Journal of Pharmacology and Experimental Therapeutics October 1997, 283 (1) 321-327;
  • You have access
    BMS-190394, a Selectin Inhibitor, Prevents Rat Cutaneous Inflammatory Reactions
    Gordon Todderud, Xina Nair, Debbie Lee, Julie Alford, Lynda Davern, Paul Stanley, Carol Bachand, Philippe Lapointe, Anne Marinier, Alain Martel, Marcel Menard, John J. Wright, Jurgen Bajorath, Diane Hollenbaugh, Alejandro Aruffo and Kenneth M. Tramposch
    Journal of Pharmacology and Experimental Therapeutics September 1997, 282 (3) 1298-1304;
  • You have access
    Patients with Delayed-Onset Sulfonamide Hypersensitivity Reactions Have Antibodies Recognizing Endoplasmic Reticulum Luminal Proteins
    Alastair E. Cribb, Lance R. Pohl, Stephen P. Spielberg and J. Steven Leeder
    Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 1064-1072;
  • You have access
    Ethodin: Pharmacological Evidence of the Interaction between Smooth Muscle and Mast Cells in the Myometrium
    María Isolde Rudolph, Maria de los Angeles García, Marcia Sepulveda, Enrique Brandan, Karin Reinicke, Sandra Nicovani and Leonor Villan
    Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 256-261;
  • You have access
    MK-801 Limits Neurovascular Dysfunction during Experimental Allergic Encephalomyelitis
    Christopher Bolton and Carolyn Paul
    Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 397-402;
  • You have access
    The Natural Product Hymenialdisine Inhibits Interleukin-8 Production in U937 Cells by Inhibition of Nuclear Factor-κB
    John J. Breton and Marie C. Chabot-Fletcher
    Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 459-466;
  • You have access
    Differential Regulation of Human Antigen-Specific Th1 and Th2 Lymphocyte Responses by Isozyme Selective Cyclic Nucleotide Phosphodiesterase Inhibitors
    David M. Essayan, Anne Kagey-Sobotka, Lawrence M. Lichtenstein and Shau-Ku Huang
    Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 505-512;
  • You have access
    Losartan, a Selective Inhibitor of Subtype AT1 Receptors for Angiotensin II, Inhibits the Binding ofN-Formylmethionyl-leucyl-phenylalanine to Neutrophil Receptors
    Silvina Raiden, Mirta Giordano, Graciela Andonegui, Analía S. Trevani, Daniel H. López, Victor Nahmod and Jorge R. Geffner
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 624-628;
  • You have access
    Cysteinyl Leukotrienes Induce P-Selectin Expression in Human Endothelial Cells via a Non-CysLT1 Receptor-Mediated Mechanism
    Karen E. Pedersen, Bruce S. Bochner and Bradley J. Undem
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 655-662;
  • You have access
    A Peptidomimetic that Specifically Inhibits Human Leukocyte Antigen DRB1*0401-restricted T Cell Proliferation
    Susan L. Woulfe, Christine P. Bono, Michelle L. Zacheis, Joseph K. Welply, Dawn A. Kirschmann, Troy A. Baudino, Yang Wang, Deborah A. Stone, Gunnar J. Hanson, Jennifer L. Vuletich, Louis J. Bedell, Benjamin D. Schwartz and Susan C. Howard
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 663-669;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics